[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021; 71, 209−49. doi:  10.3322/caac.21660
[2] Denisenko TV, Budkevich IN, Zhivotovsky B. Cell death-based treatment of lung adenocarcinoma. Cell Death Dis, 2018; 9, 117. doi:  10.1038/s41419-017-0063-y
[3] Zhang L, Lei YL, Zhang Y, et al. Silencing of PRR11 suppresses cell proliferation and induces autophagy in NSCLC cells. Genes Dis, 2018; 5, 158−66. doi:  10.1016/j.gendis.2017.12.003
[4] Cao DD, Sha J, Cui R, et al. Advances in research of spreading through air spaces and the effects on the prognosis of lung cancer. Cancer Manag Res, 2019; 11, 9725−32. doi:  10.2147/CMAR.S232187
[5] Jonna S, Subramaniam DS. Molecular diagnostics and targeted therapies in non-small cell lung cancer (NSCLC): an update. Discov Med, 2019; 27, 167−70.
[6] Huang YJ, Ni R, Wang J, et al. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Biomed Pharmacother, 2019; 109, 1851−9. doi:  10.1016/j.biopha.2018.09.151
[7] Lee KM, Guerrero-Zotano AL, Servetto A, et al. Proline rich 11 ( PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer. Nat Commun, 2020; 11, 5488. doi:  10.1038/s41467-020-19291-x
[8] Stefaniuk P, Szymczyk A, Podhorecka M. The Neutrophil to lymphocyte and lymphocyte to Monocyte ratios as new prognostic factors in hematological malignancies - a narrative review. Cancer Manag Res, 2020; 12, 2961−77. doi:  10.2147/CMAR.S245928
[9] Wei B, Li CS. Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease. J Int Med Res, 2018; 46, 3890−902. doi:  10.1177/0300060518781642
[10] Wang XE, Wang YH, Zhou Q, et al. Immunomodulatory effect of Lentinan on aberrant T subsets and cytokines profile in non-small cell lung cancer patients. Pathol Oncol Res, 2020; 26, 499−505. doi:  10.1007/s12253-018-0545-y